Home › Hemophilia B › California › Sacramento
Hemophilia B clinical trials in Sacramento, CA
4 studies for Hemophilia B are looking for participants at sites in and around Sacramento (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
RecruitingPhase 3
- UC Davis Health, Sacramento
- UC Davis Ambulatory Care Clinic, Sacramento
- UC Davis Hemophilia Treatment Center, Sacramento
- and 1 more
A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
RecruitingPhase 1/2
- University of California Davis, Sacramento
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
RecruitingObservational study
- University of California at Davis Hemophilia Treatment Center, Sacramento
SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
RecruitingPhase 4
- University of California at Davis UC Davis Hemostasis and Thrombosis Center, Sacramento
Hemophilia B trials in other cities
- Philadelphia, PA5 studies
- Houston, TX4 studies
- Los Angeles, CA4 studies
- Atlanta, GA4 studies
- Ann Arbor, MI4 studies
- San Francisco, CA3 studies
- Indianapolis, IN3 studies
- Seattle, WA3 studies
- Greenville, NC3 studies
- Nashville, TN3 studies
- Gainesville, FL3 studies
Other studies in Sacramento
- Non-Small Cell Lung Cancer29 studies
- Lung Cancer22 studies
- Breast Cancer20 studies
- Prostate Cancer19 studies
- Metastatic Cancer16 studies
- Acute Myeloid Leukemia12 studies
- Heart Failure12 studies
- Pancreatic Cancer12 studies
- Cancer (all types)11 studies
- Colon Cancer11 studies
- Bladder Cancer10 studies
- Colorectal Cancer10 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.